The use of vaccines for prevention of seasonal and pandemic influenzaArchived
On 3 October 2011 European Centre for Disease Prevention and Control (ECDC) and representatives of the European Vaccine Manufacturers met at ECDC in Stockholm for a regular scheduled meeting about the use of vaccines for prevention of seasonal and pandemic influenza. ECDC Director Marc Sprenger opened the meeting and ECDC influenza experts held different presentations, such as burden of influenza disease in the EU, risk groups for severe influenza disease, personal protective measures, pandemic influenza preparedness, seasonal influenza vaccines, communication.
The Declarations of Interest for ECDC Influenza Staff and the ECDC Director are available here under ECDC Transparency.
Training workshop on vaccine safety for Member States, building on the experience obtained in the ECDC vaccine safety project VAESCOArchived
ECDC organised a workshop aimed at the Member States not participating in the ECDC Vaccine safety network.
European Immunisation Week, 2012Archived
ECDC marked the European Immunisation Week with a focus on assisting EU Member States eliminate measles in their population. The root cause of the continued measles transmission in the EU is the sub-optimal uptake of MMR vaccination over several years.
Individual decision-making and childhood vaccination
ECDC organised a meeting among invited experts to exchange cross-disciplinary perspectives on the issue of MMR vaccination refusal among the general European population.
Third meeting on use of vaccines for prevention of influenza
February 2013, European Centre for Disease Prevention and Control (ECDC) and representatives of Vaccines Europe met at ECDC in Stockholm for a regular scheduled meeting about the use of vaccines for prevention of influenza.